Novo Nordisk

News

WhatsApp lands Moderna in hot water with PMCPA

A WhatsApp message has earned Moderna a reprimand from the UK's Prescription Medicines Code of Practice Authority (PMCPA), with Novo Nordisk, Otsuka, AstraZeneca, and Daiichi Sankyo also fo

News

Novo joins Lilly in asking FDA for ban on GLP-1 compounding

Novo Nordisk has asked the FDA to stop compounding pharmacies making cheaper versions of its semaglutide-based therapies for obesity and diabetes, saying the drug is too complex to be made

News

Novo Nordisk closes on EU okay for haemophilia antibody

Novo Nordisk's anti-TFPI antibody concizumab has been backed for approval in the EU as a once-daily drug to prevent bleeding episodes in people with haemophilia.

News

Lawmaker asks FTC to probe Novo/Catalent deal

US Senator Elizabeth Warren has asked the Federal Trade Commission (FTC) to look into a $16.5 billion deal that would give Novo Nordisk control of manufacturing facilities currently operate

R&D

Weight loss gold rush: Developers vie for next blockbuster t...

Weight loss treatments are rapidly becoming a focal point for pharma R&D, driven by the commercial success of Eli Lilly and Novo Nordisk’s therapies.

News

Disparate global Wegovy prices listed at congressional hearing

Novo Nordisk CEO reticent on lowering semaglutide prices

Novo Nordisk chief executive Lars Fruergaard Jørgensen was taken to task by US lawmakers over the price of the company's semaglutide drugs for diabetes and obesity at a congressional hearin

WhatsApp lands Moderna in hot water with PMCPA

Novo joins Lilly in asking FDA for ban on GLP-1 compounding

Novo Nordisk closes on EU okay for haemophilia antibody

Lawmaker asks FTC to probe Novo/Catalent deal

Weight loss gold rush: Developers vie for next blockbuster t...

Novo Nordisk CEO reticent on lowering semaglutide prices

CDC panel votes to scrap hepatitis B birth dose advice

How to meet your physicians where they are online

Novo Nordisk

Editor's Picks